SMS Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 30, 2025, recommended Final Dividend of Rs. 0.40 per equity share.
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.2 pts less than Nifty Microcap 250 and 2.0 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Directors of SMS Pharmaceuticals Limited, at its meeting held on May 30, 2025, recommended a Final Dividend of Rs. 0.40 per equity share. The dividend is subject to approval by shareholders at the upcoming Annual General Meeting. The record date and payment timeline will be communicated separately by the company. This is a fixed-amount per-share dividend with no change-of-capital event attached.
The Rs. 0.40 per share dividend offers a modest cash return to shareholders pending AGM approval. Without the current share price or prior-year dividend, the relative attractiveness of this payout cannot be determined from this filing alone.